Novartis' MS Drug Patent Upheld And Generic Ruled Infringing
Novartis Pharmaceuticals Corp. beat back a challenge to its blockbuster multiple sclerosis drug Gilenya in a Delaware federal court ruling unsealed on Monday, with the judge finding Novartis' patent valid and...To view the full article, register now.
Already a subscriber? Click here to view full article